首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1566176

真皮填充剂市场规模、份额、成长分析（按材料、按产品、按地区）- 产业预测，2024-2031 年

Dermal Fillers Market Size, Share, Growth Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly ), Fat Fillers, and Others), By Product, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年真皮填充剂市场规模为50.5亿美元，从2023年的54.2亿美元成长到2031年的96亿美元，复合年增长率预计为7.4%。

由于皮肤过早老化案例的增加以及对微创手术选择的日益偏好，全球真皮填充剂市场正在显着成长。对皮肤填充剂手术的需求不断增加、新兴行业参与者的产品多样化以及领先公司对产品认证不断增加，进一步推动了这种快速增长。值得注意的是，男性注射填充剂采用率的上升是促进市场扩张的关键趋势。儘管男性消费者目前在美容服务中占少数，但他们的参与度正在成长，特别是在北美和欧洲，特别是在富裕的社会经济群体中。资料显示，2019年男性占神经调节剂市场的10%，预计2031年将增加至15%。此外，真皮填充剂和生物刺激剂的男性使用者预计将从 2019 年的 5% 增加到 2031 年的 7%。目前，调变器的市场渗透率约为 5%，真皮填充剂和生物刺激剂的市场渗透率约为 4%。在美国，真皮填充剂市场预计在未来的预测期内将以有利的复合年增长率持续增长，反映出消费者人口结构和美容行业偏好的不断变化。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

AbbVie Inc.（Allergan Plc）
Galderma SA
Medytox Inc.
Merz Pharma GmbH & Co. KGaA
Revance Therapeutics, Inc.
Sinclair Pharma（Huadong Medicine Co., Ltd.）
Teoxane Laboratories
Suneva Medical, Inc.
Laboratoires Vivacy SAS
Prollenium Medical Technologies
Cytophil, Inc.
Bioxis Pharmaceuticals
Laboratoires Fillmed
Zimmer Aesthetic
Anika Therapeutics, Inc.
IBSA Nordic ApS
Givaudan
DSM
Amalian
Contura International Ltd.

简介目录

Product Code: SQMIG35A2642

Dermal Fillers Market size was valued at USD 5.05 billion in 2022 and is poised to grow from USD 5.42 billion in 2023 to USD 9.6 billion by 2031, growing at a CAGR of 7.4% in the forecast period (2024-2031).

The global dermal filler market is experiencing significant growth driven by increasing instances of early skin aging and a growing preference for minimally invasive surgical options. This surge is further propelled by heightened demand for dermal filler procedures, a greater variety of products from emerging industry players, and an uptick in product approvals by major companies. Notably, the rising adoption of injectable fillers among men is a key trend contributing to market expansion. Although male consumers currently represent a minority in aesthetic services, their participation is growing, particularly in North America and Europe, especially within affluent socioeconomic groups. Data indicates that men comprised 10% of the neuromodulator market in 2019, with projections suggesting this will increase to 15% by 2031. Additionally, male users of dermal fillers and biostimulators are expected to climb from 5% in 2019 to 7% by 2031. As of now, neuromodulators have a market penetration of approximately 5%, while dermal fillers and biostimulators sit at about 4%. In the U.S., the dermal fillers market is poised for sustainable growth at a favorable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the ongoing shifts in consumer demographics and preferences in the aesthetics industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Dermal Fillers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Dermal Fillers Market Segmental Analysis

Global Dermal Fillers Market is segmented by Material, Product, Application, End Use, and region. Based on Material, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, and Others. Based on Product, the market is segmented into Biodegradable, and Non-Biodegradable. Based on Application, the market is segmented into Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others. Based on End Use, the market is segmented into Specialty & Dermatology Clinics, Hospitals & Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Dermal Fillers Market

The rapid growth of the non-surgical dermatological procedures market is a significant driver for the dermal fillers market, fueled by their attractive benefits such as immediate results, cost-effectiveness, and a lower risk profile compared to invasive surgery. The rising societal emphasis on aesthetic enhancement and the desire for a youthful appearance have propelled the demand for these minimally invasive solutions. Injectable dermal fillers, which effectively address concerns like thin lips, facial contours, wrinkles, and scars, are becoming increasingly popular. In 2021, the substantial volume of non-surgical procedures, particularly an increase in demand among plastic surgeons, indicates a promising trajectory for the dermal fillers market.

Restraints in the Dermal Fillers Market

The high costs associated with dermal filler procedures, notably those involving fat face treatments and polymethyl-methacrylate microspheres, present significant market restraints for the dermal fillers sector. For instance, the average expense of polymethyl-methacrylate microspheres is approximately USD 1,058, while a fat face operation averages around USD 2,508, according to the American Society of Plastic Surgeons. Such substantial financial commitments may discourage potential patients, leading to slower adoption rates of these procedures. Consequently, the elevated price points are anticipated to hinder overall market expansion, limiting accessibility and curbing growth potential within the dermal fillers industry.

Market Trends of the Dermal Fillers Market

The dermal fillers market is witnessing a significant shift, with growing interest across diverse demographic groups, particularly among men seeking non-invasive aesthetic enhancements. As more men recognize the impact of aging and gravity on their facial appearance, demand for facial filler treatments is surging, attributed to their efficacy and minimal recovery time. According to the ISAPS Global Survey Results 2020, men accounted for approximately 12.2% of all global non-surgical procedures involving hyaluronic acid. This trend suggests a burgeoning patient base as dermatologists increasingly cater to male clients, propelling market growth and expanding opportunities for industry players throughout the forecast period.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Case Study Analysis
Pricing Analysis
Clinical Trials
Patent Analysis
Technology Analysis

Dermal Fillers Market, By Material

Market Overview
Hyaluronic Acid
Calcium Hydroxylapatite
Poly-L-lactic Acid
PMMA (Poly (Methyl Methacrylate))
Fat Fillers
Others

Dermal Fillers Market, By Product

Market Overview
Biodegradable
Non-Biodegradable

Dermal Fillers Market, By Application

Market Overview
Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others

Dermal Fillers Market, By End User

Market Overview
Specialty & Dermatology Clinics
Hospitals & Clinics
Others

Dermal Fillers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AbbVie Inc. (Allergan Plc)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medytox Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharma GmbH & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinclair Pharma (Huadong Medicine Co., Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teoxane Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoires Vivacy SAS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prollenium Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytophil, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioxis Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoires Fillmed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Aesthetic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBSA Nordic ApS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Givaudan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSM
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amalian
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Contura International Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments